Open Access

Using nuclear scintigraphy to accelerate the diagnosis of ATTR-CM

Event: ICNC-CT 2021
Topic: Inflammation, Infection, and Infiltrative Cardiovascular Disorders
Session type: Satellite Symposium
Sponsored by Pfizer
Date: 10 May 2021
Time: 16:15 - 17:00

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Welcome and introduction.

Speaker: Doctor S. Dorbala (Boston, US)
Thumbnail

ATTR-CM: Raising suspicion of a complex disease.

Speaker: Doctor S. Staempfli (Zurich, CH)
Thumbnail

Nuclear scintigraphy: the key to non-invasive diagnosis of ATTR-CM.

Speaker: Doctor S. Dorbala (Boston, US)
Thumbnail

Sharing experiences of a collaborative approach to diagnosing ATTR-CM.

Speaker: Doctor R. Bonfiglioli (Bologna, IT)
Thumbnail

Q&A / discussion.

Thumbnail

4 speakers from this session

Doctor Sharmila Dorbala

Brigham and Women's Hospital, Boston (United States of America)
13 presentations
0 follower

Doctor Simon Staempfli

University Heart Center, Zurich (Switzerland)
2 presentations
0 follower

Doctor Sharmila Dorbala

Brigham and Women's Hospital, Boston (United States of America)
13 presentations
0 follower

Doctor Rachele Bonfiglioli

S. Orsola-Malpighi Policlinic, Bologna (Italy)
1 presentation
0 follower

Related content

ESC Premium Access

Myocarditis associated with COVID vaccines

4 December 2021

ESC Premium Access

Personalized Approaches to antiplatelet treatment in ACS-PCI patients

3 December 2021

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

This platform is supported by

logo Novo Nordisk